- Home
- VRAX vs EPWK Comparison
VRAX vs EPWK Comparison
Compare VRAX & EPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- EPWK
- Stock Information
- Founded
- VRAX 2013
- EPWK 2011
- Country
- VRAX United Kingdom
- EPWK China
- Employees
- VRAX N/A
- EPWK N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EPWK
- Sector
- VRAX Health Care
- EPWK
- Exchange
- VRAX Nasdaq
- EPWK Nasdaq
- Market Cap
- VRAX 2.8M
- EPWK 2.3M
- IPO Year
- VRAX 2022
- EPWK 2025
- Fundamental
- Price
- VRAX $0.52
- EPWK $0.08
- Analyst Decision
- VRAX Strong Buy
- EPWK
- Analyst Count
- VRAX 1
- EPWK 0
- Target Price
- VRAX $3.00
- EPWK N/A
- AVG Volume (30 Days)
- VRAX 278.3K
- EPWK 159.0M
- Earning Date
- VRAX 01-01-0001
- EPWK 10-24-2025
- Dividend Yield
- VRAX N/A
- EPWK N/A
- EPS Growth
- VRAX N/A
- EPWK N/A
- EPS
- VRAX N/A
- EPWK N/A
- Revenue
- VRAX $6,331.00
- EPWK $20,164,008.00
- Revenue This Year
- VRAX $217,274.83
- EPWK N/A
- Revenue Next Year
- VRAX N/A
- EPWK N/A
- P/E Ratio
- VRAX N/A
- EPWK N/A
- Revenue Growth
- VRAX N/A
- EPWK 10.25
- 52 Week Low
- VRAX $0.52
- EPWK $0.06
- 52 Week High
- VRAX $3.20
- EPWK $26.00
- Technical
- Relative Strength Index (RSI)
- VRAX 29.78
- EPWK 32.57
- Support Level
- VRAX $0.57
- EPWK $0.07
- Resistance Level
- VRAX $0.64
- EPWK $0.16
- Average True Range (ATR)
- VRAX 0.04
- EPWK 0.02
- MACD
- VRAX -0.01
- EPWK 0.02
- Stochastic Oscillator
- VRAX 0.06
- EPWK 14.75
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.